OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
April 15, 2021
Rosanne Rotondo talks to Pharm Exec about recent breakthroughs in the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis and the work of Novartis’ other Global Health Flagship Programs.
April 13, 2021
Draft plan looks beyond the immediate European health challenges.
March 11, 2021
Latest proposal explores boosting the powers of the EMA.
February 26, 2021
Rajit Kamal, Vice President, Asia Pacific for DePuy Synthes, a Johnson & Johnson company, offers recommendations for those wishing to secure an expatriate assignment with their company.
February 16, 2021
Donald Macarthur and Dr. Meriem Bouslouk-Marx discuss post-approval findings of national committees in Europe charged with deciding the best strategy to use a new COVID-19 vaccine in their populations.
February 11, 2021
Can private sector serve public interests in battling rare diseases?
February 10, 2021
How the unfolding of notable infringement claim could alter commercial approaches for players in wider CBD treatment field.
January 21, 2021
There is considerable variation in the regulatory approach to medical cannabis between European countries. Yet, despite the complexity, there are clear routes to market, reports Peter Kohut.
January 12, 2021
On December 24, 2020, the UK finally agreed a Trade and Cooperation Agreement (TCA) with the EU. Cliodhna McDonough offers some initial thoughts on the implications of the TCA on the life sciences sector.
EU tasked with translating bold declarations into reality.